Effector Therapeutics Inc Tangible Net Worth Ratio
Effector Therapeutics Inc tangible net worth ratio. Effector Therapeutics Inc (EFTR) has a Tangible Net Worth Ratio of 100.0% as of March 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($827.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check how strategically is Effector Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Effector Therapeutics Inc (2021–2022)
Tangible net worth ratio of Effector Therapeutics Inc from 2021 to 2022. This chart shows how Effector Therapeutics Inc's Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2022. As of March 2024, the ratio stands at 100.0%, reflecting net assets of $827.00K with intangible assets of $0.00 USD. See Effector Therapeutics Inc (EFTR) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Effector Therapeutics Inc Tangible Net Worth Ratio by Year (2021–2022)
Effector Therapeutics Inc tangible net worth ratio by year from 2021 to 2022. The table below presents the year-by-year Tangible Net Worth Ratio for Effector Therapeutics Inc from 2021 to 2022, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Effector Therapeutics Inc.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $3.90 Million | $0.00 | $29.08 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $17.28 Million | $0.00 | $54.06 Million | — |